Skip to the page content
Your donations
Passes our checks

Roivant Social Ventures Inc

EIN 83-3947490 · New York, NY

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthStrong93 out of 100GovernanceFair62 out of 100Impact evidenceDescribes programsHow well its results are evidenced

Points to look into

  • It reported loans to or from officers, directors or other insiders.

These come from the organization's own tax return. There may be a good explanation; ask the charity.

What it says it does

SEE SCHEDULE OOUR MISSION IS TO IMPROVE EQUITY IN HEALTH CARE ACCESS AND OUTCOMES ACROSS GEOGRAPHIES, SOCIOECONOMICS, AND DEMOGRAPHICS ON A NOT-FOR-PROFIT, CHARITABLE BASIS. WE USE INNOVATIONS IN SCIENCE AND TECHNOLOGY TO CHALLENGE AND ADVANCE THE NORMS OF BIOPHARMA AND HEALTH CARE DELIVERY. OUR WORK IS ACROSS TWO STRATEGIES: (I) INVESTMENTS AND INCUBATION LEADERSHIP TO EARLY-STAGE INNOVATIVE HEALTH ACCESS, MANUFACTURING, AND DRUG DEVELOPMENT ORGANIZATIONS WITH NO OR LOW-COST "PATIENT" CAPITAL AND RESOURCES; (II) CHARITABLE PARTNERSHIPS AND EDUCATIONAL INITIATIVES ACROSS INDUSTRY, PATIENT ADVOCACY, AND INVESTORS ACCELERATING DEVELOPMENT OF NEW MEDICINES.

Income
$306,829
Spending
$287,235
Spent on programs
57%
Reserves
16.1 months of spending
Largest source of income
donations and private grants, 99%
Employees
0
Volunteers
47
Highest pay
$210.7 million, director and secretary

Source: Form 990 for the year ending March 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Strong: 93 out of 100. Higher than 67% of charities in its peer group (philanthropy, $250k to $1m).

  • Reserves

    35 of 35

    Spendable reserves would cover 16.1 months of spending.

  • Debt

    20 of 20

    It owes 6% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 6% of income.

  • Income trend

    15 of 15

    Income rose 148% on the year before.

  • Spending floor

    8 of 15

    57% of spending went to programs and raising each dollar of donations cost 8 cents.

Source: Form 990 for the year ending March 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Fair: 62 out of 100. Higher than 35% of charities in its peer group (philanthropy, $250k to $1m).

  • Independent board

    5 of 25

    0 of 5 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Pay set independently

    0 of 5

    Reports no independent review process for its chief executive's pay.

  • Independent check of accounts

    12 of 15

    Its accounts were reviewed or compiled by an independent accountant, but not audited.

  • No reported misuse

    0 of 10

    Reports at least one of: diversion of assets, excess benefits, loans to insiders.

Source: Form 990 for the year ending March 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (1)
  1. $163,370 spent. SEE SCHEDULE OTHE ORGANIZATION HAD THE FOLLOWING INITIATIVES FOR THE FISCAL-YEARENDING MARCH 31, 2025:(I) TEACHING ROIVANT SOCIAL VENTURES' "MAKING MEDICINES" COURSE AT THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL'S ESHELMAN SCHOOL OF PHARMACY, THE NUMBER ONE RANKED PHARMACY SCHOOL IN THE UNITED STATES. WE DESIGNED AND LAUNCHED THIS INNOVATIVE COURSE IN 2023 TO INTRODUCE PHARMD STUDENTS TO THE NEW DRUG APPROVAL PROCESS AND KEY ISSUES IN DRUG DISCOVERY, PRE-CLINICAL TESTING, CLINICAL TRIALS, FDA APPROVAL, AND GLOBAL ACCESS TO MEDICINES. THE COURSE IS IN HIGH DEMAND AND RECEIVED MULTIPLE TEACHING AWARDS. (II) GROWING ROIVANT SOCIAL VENTURES' INAUGURAL ACCESS TO MEDICINES PHARMA INTERNSHIPS AND ACCESS TO MEDICINES GLOBAL FELLOWSHIPS FOR TALENTED PHARMD STUDENTS FROM GROUPS WITH DISPROPORTIONATE UNMET NEEDS IN MEDICINE. IN 2023 THE PROGRAM PROVIDED REAL-WORLD DRUG DEVELOPMENT EXPERIENCE TO FOUR HIGHLY QUALIFIED PHARMD STUDENTS. IN 2024 WE EXPANDED THE PROGRAM TO FIVE STUDENTS. (III) CONTINUING OUR THOUGHT LEADERSHIP CAMPAIGN THROUGH HOSTING EVENTS LIKE "INCREASING IMPACT: LEVERAGING DATA TO DRIVE HEALTHCARE ACCESS AND ADVANCEMENT," THAT PROVIDED INCREASED VISIBILITY AND EDUCATION ON ISSUES IN HEALTHCARE ACCESS, AND SPEAKING AT EVENTS WITH ORGANIZATIONS LIKE THE TERMEER FOUNDATION, BIO'S CEO AND INVESTOR CONFERENCE, THE ADVANCING WOMEN'S LEADERSHIP IN PHARMA AND HEALTHCARE CONFERENCE, THE NATIONAL VACCINE LAW CONFERENCE, AND 50/50 WOMEN ON BOARDS. (IV) LAUNCHED OUR INAUGURAL CONVERGENCE FORUM FELLOWSHIPS, WHICH PROVIDED SUPPORT FOR HIGHLY TALENTED FIRST-TIME FEMALE AND UNDERREPRESENTED CEOS TO ATTEND AN INTIMATE, INVITATION ONLY CONFERENCE OF PROMINENT HEALTHCARE LEADERS.(V) LAUNCHING OUR HEALTH EQUITY SPOTLIGHT SERIES, WHICH HIGHLIGHTS ORGANIZATIONS INCREASING ACCESS TO RESEARCH, MEDICINE, AND MEDICAL CARE FOR UNDERSERVED PATIENT GROUPS.

Source: Form 990 for the year ending March 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending March 2025.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since September 2020.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.